Skip to Main Content

The Three Column People Listing

Description:

This layout view displays the faculty members in a single columned table. Use this view to display a limited amount of information for a faculty listing containing a relatively small number of faculty members.
  • Chadi Abdallah

    Associate Professor of Psychiatry; Deputy Director for Research, and Director of Neuroimaging, Clinical Neuroscience Division, VA National Center for PTSD

    Dr. Chadi G. Abdallah has expertise in antidepressants clinical trials, translational clinical neuroscience, multimodal neuroimaging, and the development of rapid acting antidepressant for the treatment of depression, PTSD and other stress-related psychiatric disorders. He employs broad range of pharmacological challenges, neuroimaging modalities, and network neuroscience approaches to study the neurobiology of depression and other psychiatric disorders and the mechanisms underlying treatment response and resistance. His research program focuses on understanding the mechanisms underlying trauma, depression, and chronic stress, with emphasis on the role of synaptic connectivity and neuroenergetics.

  • Jorge Aguilar-Zanatta

    Dr. Jorge Aguilar-Zanatta came to Yale as a Psychosomatic Medicine Fellow after completing an Adult Psychiatry Residency at Creedmoor Psychiatric Center in Queens, New York. He obtained his medical degree from Ross University School of Medicine and Universidad Autonoma de Guadalajara, Mexico. He joined Yale-New Haven Hospital's Psychological Medicine Department as a Consult Psychiatrist for the Behavioral Intervention Team and Consult Psychiatry Service. In addition, Dr. Aguilar-Zanatta served as an HIV Psychiatry Attending at the Nathan Smith Clinic. Dr. Aguilar-Zanatta also provided General Psychiatric services at Yale's Primary Care Clinic. He Co-Led the response team and de-escalation sub-committee and provided consultation to the Prevention and Management of the Disruptive Patient Initiative. His interests include Psychosomatic Medicine, Addiction Medicine, HIV Psychiatry, and Trauma Surgery Psychiatry. At Yale, he instructs fellows, residents, nurse practitioners and medical students. He is currently the Director of Consultation Psychiatry at Danbury Hospital.

  • Kyung-Heup Ahn

    Assistant Professor of Clinical Psychiatry

    Research Interests
    • Affective Disorders, Psychotic
    • Schizophrenia Spectrum and Other Psychotic Disorders
    Clinical Interests
    • Anxiety
    • Depression
    • Obsessive-Compulsive Disorder
    • Schizophrenia
    • Panic Disorder
    • Substance-Related Disorders
  • Associate Professor of Psychiatry and of Neuroscience; Director, Minority Recruitment, Psychiatry Department; Director, Postdoctoral Affairs, Psychiatry Department

    Research Interests
    • Acetylcholine
    • Electrophysiology
    • Glutamates
    • Interneurons
    • Memory
    • Neurobiology
    • Nicotine
    • Psychiatry
    • Puberty
    • Signal Transduction
    • Prefrontal Cortex
    • Kisspeptins
  • Hamada Hamid Altalib

    Associate Professor of Neurology and of Psychiatry

    Clinical Interests
    • Adult

    Dr. Altalib is the Director of the Veteran Administration (VA) Epilepsy Center of Excellence in West Haven, CT, where he oversees and provides direct care for Veterans with epilepsy throughout the greater New England region. He helped established a VA Neurobehavioral clinic, which provides clinical care for Veterans who suffer from emotional distress and/or behavioral problems associated with neurological conditions (such as traumatic brain injury, stroke, and epilepsy). At Yale University he also provides care for people with neurological injury that impact emotional processing. For instance, epilepsy, traumatic brain injury, movement disorders (and their treatments) can affect brain circuits and chemistry and lead to mood, anxiety, and even psychotic disorders. Furthermore, neuropsychiatric conditions such functional movement disorder and psychogenic non-epileptic seizures are managed in his clinic.

    Dr. Altalib is also the Director of the Yale Epilepsy Outcomes Research Program, in which he oversees clinical trials and cohort studies related to epilepsy interventions. In addition to seizure control outcomes, his research explores psychiatric co-morbidity of neurologic disease. He is currently the primary investigator of a studies examining the neurologic substrates of depression in people with epilepsy; the burden of psychogenic non-epileptic seizures in the Veteran population; and measuring coordination of health care using social network analysis methods.

  • Gustavo Angarita-Africano

    Associate Research Scientist in Psychiatry; Inpatient Chief of the Clinical Neuroscience Research Unit (CNRU), Psychiatry; Medical Director, Forensic Drug Diversion Clinic (ForDD)

    Clinical Interests
    • Psychiatry
    • Substance-Related Disorders

    Experiencing the impact of the cocaine epidemic in my native Colombia led me to pursue a career dedicated to the improved understanding and treatment of cocaine addiction. Since completing Clinical Training and becoming U.S Board Certified in Adult Psychiatry and Addictions Psychiatry in 2012, I have developed academic interest in the regulation of cocaine self-administration in humans, the validation of Remote Wireless Sensor Network (RWSN) technology for detecting cocaine use, and the role of cocaine-induced deficits in sleep in the putative therapeutic effects of the atypical stimulant, modafinil. Currently; my main career interests lie in the development of neurobiologically informed medication treatments for cocaine dependence, such as the ones based on homeostatic changes on the glutamatergic pathways. As an Assistant Chief of the Clinical Neuroscience Research Unit (CNRU) of the Connecticut Mental Health Center (CMHC), I provide care for the patients who are admitted on our floor in order to participate in research studies or in order to receive treatment for the psychiatric conditions afflicting them. This setting fosters collaboration with other clinicians, researchers, as well as teaching of Medical Students and Psychiatry Residents

  • Aniyizhai Annamalai

    Associate Professor of Psychiatry; Director, Adult Refugee clinic; Director, Wellness Center, Connecticut Mental Health Center

    Research Interests
    • Refugees
    • Diseases
    • Psychiatry and Psychology
    • Health Care

    My training was in a dual Internal Medicine/Psychiatry residency program. My clinical interests are in providing care to patients with both medical and mental health problems. My academic interests are in integrating primary care and mental health services. Two populations I work with are refugees and people with serious mental illness. I strongly believe that students and residents in any discipline should be well trained in both physical and mental aspects of illness enabling them to have a holistic approach to patient care.

  • Alan Anticevic

    Associate Professor of Psychiatry; Director, Division of Neurocognition, Neurocomputation, and Neurogenetics (N3), Psychiatry

    Research Interests
    • Affect
    • Mental Disorders
    • Cognition
    • Diagnosis, Computer-Assisted
    • Emotions
    • Memory, Short-Term
    • Schizophrenia
    • Computational Biology
    • Substance-Related Disorders
    • Neuroimaging
    Clinical Interests
    • Adult

    Dr. Anticevic trained in Clinical Psychology and Cognitive Neuroscience at Washington University in St. Louis where he trained with Drs. Deanna Barch and David Van Essen. Following graduate training, Dr. Anticevic completed his internship in Clinical Neuropsychology at Yale University. After internship, he joined the Yale University Department of Psychiatry as research faculty while concurrently serving as the Administrative Director for the Center for the Translational Neuroscience of Alcoholism. Subsequently, he was appointed as an Assistant Professor of Psychiatry and Psychology at the Yale University School of Medicine, where he directs a clinical neuroimaging laboratory focused on severe mental illness. Dr. Anticevic is a recipient of the NARSAD Young Investigator Award, the International Congress of Schizophrenia Research Young Investigator Award, the NIH Director's Early Independence Award, the NARSAD Independent Investigator Award and the Klerman Prize for Exceptional Clinical Research. He currently serves as the Director of the Division of Neurocognition, Neurocomputation, and Neurogenetics (N3) at Yale School of Medicine.

    His group's research focus is centered on computational and cognitive neuroscience of mental illness. Specifically, Dr. Anticevic's group is interested in characterizing neural mechanisms involved in higher order cognitive operations, such as working memory, as well as their interaction with neural systems involved in affective processes, with the aim of understanding how these computations may go awry in the context of severe mental illness . Methodologically, his group uses the combination of task-based, resting-state, pharmacological multi-modal neuroimaging, as well as computational modeling approaches to map neural alterations that lead to poor mental health outcomes. The overarching goal of the group is to develop neurobiologically principled and computationally grounded mapping between neural and behavioral levels of analyses in people to inform personalized and rational treatment design for mental health symptoms.

  • Bachaar Arnaout

    Clinical Instructor, Psychiatry

    Bachaar Arnaout, MD, is Assistant Professor of Psychiatry at the Yale School of Medicine, and serves as Director of the Detoxification and Addiction Stabilization Service and Medical Director of the Psychosocial Residential Rehabilitation Treatment Program at VA Connecticut Healthcare System. After graduating from the Jagiellonian University in Kraków, Poland, Dr. Arnaout trained in psychiatry at St. Luke’s-Roosevelt Hospital Center in New York, where he also completed the Intensive Psychoanalytic Psychotherapy Program at the William Alanson White Institute of Psychiatry, Psychoanalysis & Psychology. He then trained in addiction psychiatry at the Yale School of Medicine, where he subsequently joined as clinical faculty in 2008 and as full-time faculty in 2016. Dr. Arnaout holds board certification in psychiatry, addiction psychiatry, addiction medicine, hospice and palliative medicine, and brain injury medicine. Dr. Arnaout’s academic interests include the psychotherapy and psychopharmacology of addiction and co-occurring disorders, and medical education. He has co-edited two books on addiction psychotherapy that draw on the theoretical framework of motivational interviewing: Handbook of Motivation and Change: A Practical Guide for Clinicians (2010) and Motivational Interviewing in Clinical Practice (2017). Dr. Arnaout was a 2017-2018 Yale Public Voices Fellow with The OpEd Project. He serves as editor-in-chief of the Carlat Addiction Treatment Report.






  • Amy Arnsten

    Albert E. Kent Professor of Neuroscience and Professor of Psychology; Member, Kavli Institute of Neuroscience at Yale University

    Research Interests
    • Aging
    • Alzheimer Disease
    • Behavioral Sciences
    • Psychology, Child
    • Mental Health
    • Neurobiology
    • Neurosciences
    • Stress Disorders, Post-Traumatic
    • Prefrontal Cortex
    • Cognitive Science

    Dr. Arnsten was raised in Maplewood, N.J. where she attended Columbia High School. She received her B.A. in Neuroscience from Brown University in 1976, and her Ph.D. in Neuroscience from UCSD in 1981. She did post-doctoral research with Dr. Susan Iversen at Cambridge University in the UK, and with Dr. Patricia Goldman-Rakic at Yale. Dr. Arnsten's research examines the neural basis of higher cognition. Her work has revealed that the newly evolved cortical circuits that underlie higher cognition are uniquely regulated at the molecular level, conferring vulnerability in mental illness and age-related cognitive disorders such as Alzheimer's Disease. Arnsten's research has led to new treatments for cognitive disorders in humans, including the successful translation of guanfacine (IntunivTM) for the treatment of ADHD and related prefrontal cortical disorders.

  • Seth Axelrod

    Associate Professor of Psychiatry; Director of Dialectical Behavior Therapy Services, Yale-New Haven Psychiatric Hospital Intensive Outpatient Program; Director of Yale Instruction/Investigation/Intervention in Emotional Lability and Dysregulation (YIELD)

    Research Interests
    • Behavior Therapy
    • Borderline Personality Disorder
    • Burnout, Professional
    • Psychiatry
    • Stress Disorders, Post-Traumatic
    • Substance Abuse Detection
    • Mindfulness
    Clinical Interests
    • Behavior Therapy
    • Borderline Personality Disorder
    • Impulsive Behavior
    • Suicide
    • Self-Injurious Behavior
    • Behavior, Addictive

    I am very interested in training clinicians in personality disorders and dialectical behavior therapy (DBT). I am particularly interested in helping therapists observe personal limits to improve treatment alliance, therapy effectiveness, and therapist satisfaction, and to reduce therapist burnout. In addition to my work at Yale, I am a trainer/consultant with Behavioral Tech, LLC, an organization developed by Dr. Marsha Linehan to disseminate DBT and other empirically supported therapies. Each spring I co-chair a conference on Borderline Personality Disorder in partnership with the National Education Alliance for BPD and co-provided by the Yale School of Medicine, Yale New Haven Psychiatric Hospital, and the Yale Stress Center.

  • Samuel Ball

    Professor of Psychiatry; Assistant Chair for Education and Career Development

    Research Interests
    • Behavior and Behavior Mechanisms
    • Mental Disorders
    • Homeless Persons
    • Personality
    • Personality Disorders
    • Psychiatry
    • Psychotherapy
    • Substance Abuse Detection
    • Treatment Outcome
    • Psychiatry and Psychology
    Clinical Interests
    • Alcohol Drinking
    • Mental Health
    • Psychiatry
    • Substance-Related Disorders

    I was born, raised, and continue to live in southern Connecticut. I received my bachelor's degree in Psychology and English from Colgate University in 1984 and then went to graduate school for Clinical Psychology at the University of Delaware where I received my master's in 1988 and doctorate in 1990. After completing my internship at Yale Medical School, I joined the faculty in the Department of Psychiatry as a Clinical Instructor and am now a Professor. In addition to my research, teaching, and faculty development responsibilities at Yale, I have held various clinical administrative leadership positions in The APT Foundation, one of the largest providers of substance abuse treatment in the state.

  • Andres Barkil-Oteo

    Assistant Clinical Professor of Psychiatry

    Dr. Andres Barkil-Oteo is a Assistant Clinical Professor of Psychiatry at Yale School of Medicine, and currently a psychiatrist consultant with Doctors Without Borders (MSF). Previously at Yale he was the Medical Director of Acute Care Services at Connecticut Mental Health Center in New Haven CT where he was involved in coordination and provision of mental health services to a large Iraqi refugee population in New Haven. Dr. Barkil-Oteo’s work focuses on using technology to increase capacity of non-specialists to deliver effective and high-quality mental health care in low-income settings. He is the co-founder of the Syrian Tele-mental Health Network, and the editor of an upcoming textbook from Oxford University Press on using telemental health in low-income settings.

  • Declan Barry

    Associate Professor of Psychiatry; Director of Pain Treatment Services, APT Foundation; Director of Research, APT Foundation

    Research Interests
    • Culture
    • Opioid-Related Disorders
    • Psychotherapy
    • Substance-Related Disorders
    • Chronic Pain
    • Psychiatry and Psychology

    Dr. Barry is a clinical psychologist and Associate Professor in the Psychiatry Department and Child Study Center at Yale School of Medicine.  His  research is aimed at: 

    1. Developing and evaluating treatments for co-occurring opioid use disorder and chronic pain  and 
    2. Examining the role of sociocultural factors in the occurrence and treatment of pain and addiction. 

    Dr. Barry is the Associate Editor of the Journal of Immigrant and Minority Health and is an editorial board member of Pain Medicine. He is also the  the Director of Pain Treatment Services and the Director of Research at the APT Foundation, a multidisciplinary clinical research unit that focuses on the study of co-occurring chronic pain and opioid use disorder.

  • Assistant Professor of Psychology and of Psychiatry

    Dr. Arielle Baskin-Sommers is a licensed clinical psychologist. She received her Sc.B. from Brown University (2007), a Ph.D. from the University of Wisconsin-Madison (2013), and completed her pre-doctoral internship and fellowship at McLean Hospital/Harvard Medical School. Substantively, her research is concentrated on understanding individual differences in cognitive and affective processes as they relate to vulnerability for disinhibitory psychopathology. Methodologically, she is interested in integrating a wide range of techniques and technologies to explore this issue. Overall, her professional career goals are based on a desire to develop both innovative theory and research in service of increasing the efficacy of clinical intervention.